Literature DB >> 16581181

Effect of metals and phenylalanine on the activity of human tryptophan hydroxylase-2: comparison with that on tyrosine hydroxylase activity.

Shintaro Ogawa1, Hiroshi Ichinose.   

Abstract

We cloned the human tryptophan hydroxylase-2 (hTPH2) gene by RT-PCR, and expressed and purified its product as a maltose-binding protein (MBP)-fusion protein. We investigated the effects of essential divalent cations and L-phenylalanine (L-Phe) on the hTPH2 activity for the first time, and compared them with those on human tyrosine hydroxylase (hTH1) activity. We found that cobaltous and manganous ions inhibited the activities of both enzymes but that hTH1 was affected at lower concentrations than hTPH2. From kinetic analyses, we found that phenylalanine acted as an inhibitor more strongly against hTPH2 than against hTH1. These data are important for elucidating the molecular mechanism underlying the alterations in the contents of serotonin and catecholamines in the brain under pathological and physiological conditions, such as hyperphenylalaninemia and chronic manganese toxicity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16581181     DOI: 10.1016/j.neulet.2006.03.031

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  15 in total

1.  Tetrahydrobiopterin treatment reduces brain L-Phe but only partially improves serotonin in hyperphenylalaninemic ENU1/2 mice.

Authors:  Tanja Scherer; Gabriella Allegri; Christineh N Sarkissian; Ming Ying; Hiu Man Grisch-Chan; Anahita Rassi; Shelley R Winn; Cary O Harding; Aurora Martinez; Beat Thöny
Journal:  J Inherit Metab Dis       Date:  2018-03-08       Impact factor: 4.982

2.  Partial biopterin deficiency disturbs postnatal development of the dopaminergic system in the brain.

Authors:  Daigo Homma; Chiho Sumi-Ichinose; Hirofumi Tokuoka; Kazuhisa Ikemoto; Takahide Nomura; Kazunao Kondo; Setsuko Katoh; Hiroshi Ichinose
Journal:  J Biol Chem       Date:  2010-11-09       Impact factor: 5.157

3.  High dose sapropterin dihydrochloride therapy improves monoamine neurotransmitter turnover in murine phenylketonuria (PKU).

Authors:  Shelley R Winn; Tanja Scherer; Beat Thöny; Cary O Harding
Journal:  Mol Genet Metab       Date:  2015-11-26       Impact factor: 4.797

4.  Blood phenylalanine reduction corrects CNS dopamine and serotonin deficiencies and partially improves behavioral performance in adult phenylketonuric mice.

Authors:  Shelley R Winn; Tanja Scherer; Beat Thöny; Ming Ying; Aurora Martinez; Sydney Weber; Jacob Raber; Cary O Harding
Journal:  Mol Genet Metab       Date:  2017-10-19       Impact factor: 4.797

5.  Hepatic cirrhosis, dystonia, polycythaemia and hypermanganesaemia--a new metabolic disorder.

Authors:  Karin Tuschl; Philippa B Mills; Howard Parsons; Marian Malone; Darren Fowler; Maria Bitner-Glindzicz; Peter T Clayton
Journal:  J Inherit Metab Dis       Date:  2008-04-04       Impact factor: 4.982

6.  Chemical biomarkers of epileptogenesis and ictogenesis in experimental epilepsy.

Authors:  Hiram Luna-Munguia; Alexander G Zestos; Stephen V Gliske; Robert T Kennedy; William C Stacey
Journal:  Neurobiol Dis       Date:  2018-10-07       Impact factor: 5.996

Review 7.  Brain dysfunction in phenylketonuria: is phenylalanine toxicity the only possible cause?

Authors:  F J van Spronsen; Marieke Hoeksma; Dirk-Jan Reijngoud
Journal:  J Inherit Metab Dis       Date:  2009-01-13       Impact factor: 4.982

8.  Melatonin and dopamine as biomarkers to optimize treatment in phenylketonuria: effects of tryptophan and tyrosine supplementation.

Authors:  Shoji Yano; Kathryn Moseley; Colleen Azen
Journal:  J Pediatr       Date:  2014-05-22       Impact factor: 4.406

9.  In vivo catecholaminergic metabolism in the medial prefrontal cortex of ENU2 mice: an investigation of the cortical dopamine deficit in phenylketonuria.

Authors:  Tiziana Pascucci; Giacomo Giacovazzo; Diego Andolina; David Conversi; Fabio Cruciani; Simona Cabib; Stefano Puglisi-Allegra
Journal:  J Inherit Metab Dis       Date:  2012-03-24       Impact factor: 4.982

10.  Modeling the cognitive effects of diet discontinuation in adults with phenylketonuria (PKU) using pegvaliase therapy in PAH-deficient mice.

Authors:  Shelley R Winn; Sandra Dudley; Tanja Scherer; Nicole Rimann; Beat Thöny; Sydney Boutros; Destine Krenik; Jacob Raber; Cary O Harding
Journal:  Mol Genet Metab       Date:  2022-03-21       Impact factor: 4.204

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.